Terminated PHASE2 INTERVENTIONAL NCT01395576

Evaluation of the Genu Neurexa Orthosis in Post Stroke Patients

Sponsor: Hadassah Medical Organization

Conditions Stroke

Updated 9 times since 2017 Last updated: May 18, 2014 Started: Feb 28, 2011 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

statistical significance of the results was reached for the 34 subjects who participated in teh study.

Other terminated trials from Hadassah Medical Organization

See all terminations from Hadassah Medical Organization

Other Stroke trials with similar outcome

Browse all Stroke trials

This PHASE2 trial investigates Stroke and is currently terminated or withdrawn. Hadassah Medical Organization leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2
Nov 2020 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 4 earlier versions

Jun 2018 — Nov 2020 [monthly]

Terminated PHASE2
May 2018 — Jun 2018 [monthly]

Terminated PHASE2
Aug 2017 — May 2018 [monthly]

Terminated PHASE2
Jan 2017 — Aug 2017 [monthly]

Terminated PHASE2

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hadassah Medical Organization
Otto Bock Healthcare Products GmbH

Data source: Hadassah Medical Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel